EVO
Price
$2.65
Change
+$0.02 (+0.76%)
Updated
Jun 23, 03:40 PM (EDT)
Capitalization
942.51M
51 days until earnings call
Intraday BUY SELL Signals
SNDL
Price
$1.43
Change
+$0.03 (+2.14%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
365.72M
45 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EVO vs SNDL

EVO vs SNDL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
EVO vs. SNDL commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVO is a Hold and SNDL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (EVO: $2.62 vs. SNDL: $1.40)
Brand notoriety: EVO and SNDL are both not notable
EVO represents the Pharmaceuticals: Generic, while SNDL is part of the Beverages: Alcoholic industry
Current volume relative to the 65-day Moving Average: EVO: 58% vs. SNDL: 138%
Market capitalization -- EVO: $942.51M vs. SNDL: $365.72M
EVO [@Pharmaceuticals: Generic] is valued at $942.51M. SNDL’s [@Beverages: Alcoholic] market capitalization is $365.72M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The market cap for tickers in the [@Beverages: Alcoholic] industry ranges from $19.33T to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.92B. The average market capitalization across the [@Beverages: Alcoholic] industry is $4.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVO’s FA Score shows that 1 FA rating(s) are green whileSNDL’s FA Score has 0 green FA rating(s).

  • EVO’s FA Score: 1 green, 4 red.
  • SNDL’s FA Score: 0 green, 5 red.
According to our system of comparison, both EVO and SNDL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVO’s TA Score shows that 3 TA indicator(s) are bullish while SNDL’s TA Score has 2 bullish TA indicator(s).

  • EVO’s TA Score: 3 bullish, 6 bearish.
  • SNDL’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, both EVO and SNDL are a bad buy in the short-term.

Price Growth

EVO (@Pharmaceuticals: Generic) experienced а -6.43% price change this week, while SNDL (@Beverages: Alcoholic) price change was -1.75% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.70%. For the same industry, the average monthly price growth was +0.08%, and the average quarterly price growth was +8.31%.

The average weekly price growth across all stocks in the @Beverages: Alcoholic industry was -3.63%. For the same industry, the average monthly price growth was -6.77%, and the average quarterly price growth was -26.80%.

Reported Earning Dates

EVO is expected to report earnings on Aug 13, 2026.

SNDL is expected to report earnings on Aug 07, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.70% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

@Beverages: Alcoholic (-3.63% weekly)

The alcoholic beverage market includes beer, wine, and spirits. From $230 billion in 2015, the industry has grown to around $250 billion by 2019. In recent years, alcoholic beverage makers have been looking to expand distribution and purchase channels, such as through online stores (e.g. e-commerce platform Drizly) and convenience stores. Anheuser-Busch In Bev and Diageo are major global alcoholic beverage companies, while U.S.-owned companies include Constellation Brands and Brown-Forman Corp. among several others.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EVO($943M) has a higher market cap than SNDL($366M). EVO (-14.935) and SNDL (-15.361) have similar YTD gains . SNDL has higher annual earnings (EBITDA): 44.9M vs. EVO (-164.48M). EVO has more cash in the bank: 464M vs. SNDL (217M). SNDL has less debt than EVO: SNDL (168M) vs EVO (387M). SNDL has higher revenues than EVO: SNDL (937M) vs EVO (745M).
EVOSNDLEVO / SNDL
Capitalization943M366M258%
EBITDA-164.48M44.9M-366%
Gain YTD-14.935-15.36197%
P/E RatioN/AN/A-
Revenue745M937M80%
Total Cash464M217M214%
Total Debt387M168M230%
FUNDAMENTALS RATINGS
EVO vs SNDL: Fundamental Ratings
EVO
SNDL
OUTLOOK RATING
1..100
6524
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
43
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9792
PRICE GROWTH RATING
1..100
6258
P/E GROWTH RATING
1..100
289
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNDL's Valuation (43) in the null industry is somewhat better than the same rating for EVO (91). This means that SNDL’s stock grew somewhat faster than EVO’s over the last 12 months.

SNDL's Profit vs Risk Rating (100) in the null industry is in the same range as EVO (100). This means that SNDL’s stock grew similarly to EVO’s over the last 12 months.

SNDL's SMR Rating (92) in the null industry is in the same range as EVO (97). This means that SNDL’s stock grew similarly to EVO’s over the last 12 months.

SNDL's Price Growth Rating (58) in the null industry is in the same range as EVO (62). This means that SNDL’s stock grew similarly to EVO’s over the last 12 months.

EVO's P/E Growth Rating (2) in the null industry is significantly better than the same rating for SNDL (89). This means that EVO’s stock grew significantly faster than SNDL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EVOSNDL
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 23 days ago
68%
Bullish Trend 8 days ago
72%
Declines
ODDS (%)
Bearish Trend 6 days ago
79%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
65%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
EVO
Daily Signal:
Gain/Loss:
SNDL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DFVQX20.050.06
+0.30%
DFA International Vector Equity I
AIVIX20.46N/A
N/A
AB International Value I
PESPX31.03N/A
N/A
BNY Mellon MidCap Index Inv
UEMPX13.48N/A
N/A
UBS Emerging Markets Equity Opp P
CMLFX62.91-0.10
-0.16%
American Funds American Mutual 529F

EVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, EVO has been loosely correlated with SNDL. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if EVO jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVO
1D Price
Change %
EVO100%
+2.34%
SNDL - EVO
42%
Loosely correlated
-1.06%
PRGO - EVO
40%
Loosely correlated
-6.34%
ACET - EVO
26%
Poorly correlated
+1.60%
ELAN - EVO
25%
Poorly correlated
-1.32%
AMPH - EVO
23%
Poorly correlated
-2.60%
More